Cargando…

In Vivo Overexpression of IL-13 Receptor α2 Chain Inhibits Tumorigenicity of Human Breast and Pancreatic Tumors in Immunodeficient Mice

Interleukin 13 receptor α2 (IL-13Rα2) chain is highly expressed on some tumor cell lines and primary cell cultures. This receptor chain plays an important role in ligand binding and internalization. To determine the functional significance of overexpression of this chain, we stably transfected IL-13...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawakami, Koji, Kawakami, Mariko, Snoy, Philip J., Husain, Syed R., Puri, Raj K.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2001
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193574/ https://www.ncbi.nlm.nih.gov/pubmed/11748276

Ejemplares similares

Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy
por: Knudson, Karin M., et al.
Publicado: (2022)

Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models
por: Nakashima, Hideyuki, et al.
Publicado: (2010)

IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer
por: Fujisawa, Toshio, et al.
Publicado: (2021)

Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma
por: Vaz, Arokia Priyanka, et al.
Publicado: (2015)

Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer
por: Fujisawa, Toshio, et al.
Publicado: (2011)

Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo
por: Fujisawa, Toshio, et al.
Publicado: (2013)

IL-13Rα2 gene expression is a biomarker of adverse outcome in patients with adrenocortical carcinoma
por: Kumar, Abhinav, et al.
Publicado: (2021)

Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma
por: Yin, De-Pei, et al.
Publicado: (2023)

Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex
por: Tollenaere, Maxim A.X., et al.
Publicado: (2023)

Identification of a novel role of IL-13Rα2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathway
por: Bhardwaj, Rukmini, et al.
Publicado: (2018)

Overexpression of Urokinase‐type Plasminogen Activator in Human Gastric Cancer Cell Line (AGS) Induces Tumorigenicity in Severe Combined Immunodeficient Mice
por: Choi, Yang‐Kyu, et al.
Publicado: (2002)

Overexpression of Betaig-h3 gene downregulates integrin α5β1 and suppresses tumorigenicity in radiation-induced tumorigenic human bronchial epithelial cells
por: Zhao, Y L, et al.
Publicado: (2002)

Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling
por: Hall, Bradford, et al.
Publicado: (2013)

Characterization of in vivo tumorigenicity tests using severe immunodeficient NOD/Shi-scid IL2Rγ(null) mice for detection of tumorigenic cellular impurities in human cell-processed therapeutic products
por: Kusakawa, Shinji, et al.
Publicado: (2015)

Overexpression of SIRT6 attenuates the tumorigenicity of hepatocellular carcinoma cells
por: Wang, Yadong, et al.
Publicado: (2017)

Effects of STC1 overexpression on tumorigenicity and metabolism of hepatocellular carcinoma
por: Leung, Cherry CT, et al.
Publicado: (2017)

Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer
por: Shi, Jingwei, et al.
Publicado: (2021)

Generation of interleukin-13 receptor alpha2 antigen expressing modified vaccinia ankara recombinant virus for potential cancer immunotherapy
por: Sato, Yuki, et al.
Publicado: (2014)

Diagnosis and Treatment of a Patient With Severe Combined Immunodeficiency Due to a Novel Homozygous Mutation in the IL-7Rα Chain
por: Mansour, Rana, et al.
Publicado: (2022)

IL2RG, identified as overexpressed by RNA-seq profiling of pancreatic intraepithelial neoplasia, mediates pancreatic cancer growth
por: Ayars, Michael, et al.
Publicado: (2017)

Overexpression of Suprabasin is Associated with Proliferation and Tumorigenicity of Esophageal Squamous Cell Carcinoma
por: Zhu, Jinrong, et al.
Publicado: (2016)

The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma
por: Yin, De-Pei, et al.
Publicado: (2022)

MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1
por: Gwiggner, Markus, et al.
Publicado: (2018)

Snail-Overexpression Induces Epithelial-mesenchymal Transition and Metabolic Reprogramming in Human Pancreatic Ductal Adenocarcinoma and Non-tumorigenic Ductal Cells
por: Liu, Menghan, et al.
Publicado: (2019)

Enhanced Interleukin (IL)-13 Responses in Mice Lacking IL-13 Receptor α 2
por: Wood, Nancy, et al.
Publicado: (2003)

IL-13Rα2 Glycosylation Holds the Dance Card for Partnering with IL-13
por: Dy, Alane B. C., et al.
Publicado: (2020)

Characterization of Chimeric Antigen Receptor Modified T Cells Expressing scFv-IL-13Rα2 after Radiolabeling with 89Zirconium Oxine for PET Imaging
por: Leland, Pamela, et al.
Publicado: (2023)

Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with (89)Zirconium oxine for PET imaging
por: Leland, Pamela, et al.
Publicado: (2023)

Anti-Tumorigenic Activities of IL-33: A Mechanistic Insight
por: Andreone, Sara, et al.
Publicado: (2020)

A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumors
por: Kim, Julius W., et al.
Publicado: (2015)

Correction: Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with (89)Zirconium oxine for PET imaging
por: Leland, Pamela, et al.
Publicado: (2023)

Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes
por: Endo, Toyoshi, et al.
Publicado: (2013)

SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells
por: Vicente, Carolina M, et al.
Publicado: (2015)

Overexpression of α3, β3 and γ2 chains of laminin-332 is associated with poor prognosis in pancreatic ductal adenocarcinoma
por: Chen, Jun, et al.
Publicado: (2018)

Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Rα, IL-13Rα1, and γc regulates relative cytokine sensitivity
por: Junttila, Ilkka S., et al.
Publicado: (2008)

Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis
por: Yao, Wantong, et al.
Publicado: (2014)

YME1L overexpression exerts pro-tumorigenic activity in glioma by promoting Gαi1 expression and Akt activation
por: Liu, Fang, et al.
Publicado: (2022)

Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer
por: Zhang, Yang, et al.
Publicado: (2022)

Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma
por: Fu, Danqi, et al.
Publicado: (2023)

Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes
por: Ulzii, Dugarmaa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hqr1709avrlp4b609njra8rcvc